Real-World Screening Data for Liver Fibrosis in Psoriasis Patients Treated with Biologics.

Journal: Journal of Nippon Medical School = Nippon Ika Daigaku zasshi
PMID: 39756942

Abstract

BACKGROUND: Metabolic dysfunction-associated steatotic liver disease (MASLD) is positively associated with the prevalence and severity of psoriasis. The fibrosis-4 (FIB-4) index was developed to predict significant liver fibrosis. Using the FIB-4 index, the present study evaluated screening data for liver fibrosis, including MASLD, in patients with refractory psoriasis treated with biologics.

Authors

  • Susumu Ichiyama
    Department of Dermatology, Nippon Medical School.
  • Michiko Ito
    Department of Dermatology, Nippon Medical School.
  • Saeko Ozaki
    Department of Dermatology, Nippon Medical School.
  • Taeang Arai
    Department of Gastroenterology and Hepatology, Nippon Medical School.
  • Masanori Atsukawa
    Department of Gastroenterology and Hepatology, Nippon Medical School.
  • Katsuhiko Iwakiri
    Department of Gastroenterology and Hepatology, Nippon Medical School.
  • Teppei Hagino
    Department of Dermatology, Nippon Medical School Chiba Hokusoh Hospital.
  • Toshihiko Hoashi
    Department of Dermatology, Nippon Medical School.
  • Naoko Kanda
    Department of Dermatology, Nippon Medical School Chiba Hokusoh Hospital.
  • Hidehisa Saeki
    Department of Dermatology, Nippon Medical School.

Keywords

External Resources

Popular Topics
Recent Journals